GUANGZHOU, China, Feb. 11, 2025 /PRNewswire/ — Vipshop Holdings Limited (NYSE: VIPS), a leading online discount retailer for brands in China ("Vipshop" or the "Company"), today announced that it plans to release its fourth quarter and full year 2024 financial results on Friday, February 21, 2025, before the US market open.

The Company will hold a conference call on Friday, February 21, 2025 at 7:00 am US Eastern Time, 8:00 pm Beijing Time to discuss the financial results.

All participants wishing to join the conference call must pre-register online using the link provided below.

Registration Link:

https://register.vevent.com/register/BI94d605c9b9f44cd984fd6a1dd0f5a6b3

Once pre-registration has been completed, each participant will receive dial-in numbers and a unique access PIN via email. To join the conference, participants should use the dial-in details followed by the PIN code.

A live webcast of the earnings conference call can be accessed at https://edge.media-server.com/mmc/p/4brks6io. An archived webcast will be available at the Company’s investor relations website at http://ir.vip.com.  

About Vipshop Holdings Limited

Vipshop Holdings Limited is a leading online discount retailer for brands in China. Vipshop offers high quality and popular branded products to consumers throughout China at a significant discount to retail prices. Since it was founded in August 2008, the Company has rapidly built a sizeable and growing base of customers and brand partners. For more information, please visit https://ir.vip.com/

Investor Relations Contact

Tel: +86 (20) 2233-0732Email: IR@Vipshop.com

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

Neurovia AI CTO at ISNR: Solving the AI Data Cost Dilemma and Unleashing Infrastructure Capacity

ABU DHABI, UAE, May 20, 2026 /PRNewswire/ — Neurovia AI, an AI…

Montage Technology Delivers Gen2 MRCD & MDB Engineering Samples for DDR5 MRDIMM

Gen2 MRCD & MDB reach 12800 MT/s, 45% higher than Gen1 products…

Innovent Receives U.S. FDA Approval for IND Application of Oral GLP-1R Agonist IBI3032

SAN FRANCISCO and SUZHOU, China, Aug. 5, 2025 /PRNewswire/ — Innovent Biologics, Inc. ("Innovent")…